Abstract: OBJECTIVES Bicalutamide is a nonsteroidal competitive inhibitor of androgens at the androgen receptor. The level of blockade that can be […]

Abstract: OBJECTIVES. The safety, efficacy, and pharmacokinetics of the nonsteroidal antiandrogen bicalutamide were investigated in a Phase II trial in 150 patients […]

Abstract: Bicalutamide, a potent nonsteroidal antiandrogenic drug devoid of hormonal agonist activity, is considered to be a pure antiandrogen. Binding […]

Abstract: The effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation (anagen hair […]

Two Year Propecia Results In this Friday’s Wall Street Journal (12-19-97), Page B1, “Bulletins from the Battle of the Baldness […]

Abstract: The opening of intracellular potassium channels is a common mechanism of action for a set of anti-hypertensive drugs that […]

Abstract: We investigated the effect of cyclosporin, as well as minoxidil, testosterone, estradiol and corticosteroid on the hair growth on […]

Abstract: Most cases of hair loss are based on premature induction of follicle regression (catagen). Deciphering the unknown regulation of catagen is […]

Abstract: Cyclosporin A (CsA), a cyclic endecapeptide, is a T cell-specific immunosuppressant and is successfully used in the field of organ […]

Abstract: We studied the effect of cyclosporin A on human hair growth using a recently described model in which isolated […]